Benin vs Burkina Faso: Access to anti-retroviral drugs, female
Benin
98.0%
in 2024
Burkina Faso
98.0%
in 2024
Benin rank
1st
Burkina Faso rank
1st
Access to anti-retroviral drugs, female over time
- Benin
- Burkina Faso
How they compare
Benin currently reports 98.0% against 98.0% in Burkina Faso, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Burkina Faso ahead.
Benin ranks 1st and Burkina Faso ranks 1st of 141 countries.
Across the 3 decades both report, Benin averaged higher in 1 and Burkina Faso in 2.
Head to head by decade
| Decade | Benin | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 10.1% | 4.6% | Burkina Faso |
| 2010s | 50.4% | 67.6% | 17.2% | Burkina Faso |
| 2020s | 93.4% | 91.8% | 1.6% | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Benin or Burkina Faso?
- Benin, at 98.0% against 98.0% in Burkina Faso as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Benin and Burkina Faso?
- 0.0%, with Benin ahead.
- How many years of comparable data are there for Benin and Burkina Faso?
- 25 years are reported by both, from 2000 to 2024.
- How do Benin and Burkina Faso rank globally for access to anti-retroviral drugs, female?
- Benin ranks 1st and Burkina Faso ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.